Metastatic melanoma patients’ sensitivity to ipilimumab cannot be predicted by tumor characteristics
Kara Rossfeld,
Erinn M. Hade,
Alexandra Gangi,
Matthew Perez,
Emily N. Kinsey,
Joanna Grabska,
Ashley Ederle,
Jonathan Zager,
April K. Salama,
Thomas E. Olencki,
Georgia M. Beasley
